BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 38431080)

  • 1. Sacral neuromodulation device biofilm differs in the absence and presence of infection, harbors antibiotic resistance genes, and is reproducible in vitro.
    Werneburg GT; Hettel D; Adler A; Mukherjee SD; Goldman HB; Rackley RR; Zillioux J; Martin SE; Gill BC; Shoskes DA; Miller AW; Vasavada SP
    Neurourol Urodyn; 2024 May; ():. PubMed ID: 38808686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urologist-perceived barriers and perspectives on the underuse of sacral neuromodulation for overactive bladder in Canada.
    Gariscsak P; Gray G; Steele S; Elterman D; Doiron RC
    Can Urol Assoc J; 2023 Jun; 17(6):E165-E171. PubMed ID: 36952298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sacral nerve stimulation for urinary urge incontinence, urgency-frequency, urinary retention, and fecal incontinence: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(3):1-64. PubMed ID: 23074472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sacral neuromodulation: Rechargeable versus non-rechargeable device. What would the patient preferences be in France?
    Gamé X; Ruffion A; Cornu JN; Phé V; Peyronnet B; Perrouin-Verbe MA; Aublant C; Adé A; Chartier-Kastler E
    Prog Urol; 2022 Sep; 32(10):672-680. PubMed ID: 35752523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of sacral neuromodulation on pudendal nerve function and female sexual function.
    Parnell BA; Howard JF; Geller EJ
    Neurourol Urodyn; 2015 Jun; 34(5):456-60. PubMed ID: 24615871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migration of a sacral neuromodulation electrode after vaginal delivery in a female patient with non-obstructive urinary retention.
    El-Akri M; Peyronnet B
    Fr J Urol; 2024 Mar; 34(6):102605. PubMed ID: 38431080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
    Girtner F; Burger M; Mayr R
    Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What uro-gynecologists should know about sacral neuromodulation (SNM) for the treatment of refractory overactive bladder.
    Oelke M; Addali M; Reisenauer C
    Arch Gynecol Obstet; 2019 May; 299(5):1243-1252. PubMed ID: 30941558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of sacral neuromodulation on pregnancy: a systematic review.
    Mahran A; Soriano A; Safwat AS; Hijaz A; Mahajan ST; Trabuco EC; Siegel SW; El-Nashar SA
    Int Urogynecol J; 2017 Sep; 28(9):1357-1365. PubMed ID: 28160010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sacral neuromodulation for female pelvic floor disorders.
    El-Azab AS; Siegel SW
    Arab J Urol; 2019 Mar; 17(1):14-22. PubMed ID: 31258941
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.